Recurrent lung cancer
Information
- Disease name
- Recurrent lung cancer
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03076164 | Completed | Phase 1/Phase 2 | A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib | March 1, 2017 | December 18, 2020 |
| NCT05632913 | Recruiting | N/A | Alpha Radiation Emitters Device for the Treatment of Recurrent Lung Cancer | July 1, 2023 | February 2027 |
| NCT05786924 | Recruiting | Phase 1 | A Study of BDTX-4933 in Patients With KRAS, BRAF and Select RAS/MAPK Mutation-Positive Cancers | April 18, 2023 | December 2026 |